Personal information

Iceland

Activities

Works (50 of 115)

Items per page:
Page 1 of 3

Data from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk

2023-03-31 | Preprint
Contributors: Thorhildur Olafsdottir; Simon N. Stacey; Gardar Sveinbjornsson; Gudmar Thorleifsson; Kristjan Norland; Bardur Sigurgeirsson; Kristin Thorisdottir; Arni Kjalar Kristjansson; Laufey Tryggvadottir; Kavita Y. Sarin et al.
Source: check_circle
Crossref

Data from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk

2023-03-31 | Preprint
Contributors: Thorhildur Olafsdottir; Simon N. Stacey; Gardar Sveinbjornsson; Gudmar Thorleifsson; Kristjan Norland; Bardur Sigurgeirsson; Kristin Thorisdottir; Arni Kjalar Kristjansson; Laufey Tryggvadottir; Kavita Y. Sarin et al.
Source: check_circle
Crossref

Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk

2023-03-31 | Preprint
Contributors: Thorhildur Olafsdottir; Simon N. Stacey; Gardar Sveinbjornsson; Gudmar Thorleifsson; Kristjan Norland; Bardur Sigurgeirsson; Kristin Thorisdottir; Arni Kjalar Kristjansson; Laufey Tryggvadottir; Kavita Y. Sarin et al.
Source: check_circle
Crossref

Supplementary Material from Loss-of-Function Variants in the Tumor-Suppressor Gene <i>PTPN14</i> Confer Increased Cancer Risk

2023-03-31 | Preprint
Contributors: Thorhildur Olafsdottir; Simon N. Stacey; Gardar Sveinbjornsson; Gudmar Thorleifsson; Kristjan Norland; Bardur Sigurgeirsson; Kristin Thorisdottir; Arni Kjalar Kristjansson; Laufey Tryggvadottir; Kavita Y. Sarin et al.
Source: check_circle
Crossref

Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study

Journal of Dermatological Treatment
2022-04-03 | Journal article
Contributors: Bardur Sigurgeirsson; Knut Schäkel; Chih-Ho Hong; Isaak Effendy; Waldemar Placek; Phoebe Rich; Deborah Keefe; Gerard Bruin; Pascal Charef; Rong Fu et al.
Source: check_circle
Crossref

Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52‐week results from MATURE, a randomized, placebo‐controlled trial

Dermatologic Therapy
2022-03 | Journal article
Contributors: Bardur Sigurgeirsson; John Browning; Stephen Tyring; Jacek C. Szepietowski; Raquel Rivera‐Díaz; Isaak Effendy; Deborah Keefe; Gerard Bruin; Bertrand Paguet; Rong Fu et al.
Source: check_circle
Crossref

Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk

Cancer Research
2021-04-15 | Journal article
Contributors: Thorhildur Olafsdottir; Simon N. Stacey; Gardar Sveinbjornsson; Gudmar Thorleifsson; Kristjan Norland; Bardur Sigurgeirsson; Kristin Thorisdottir; Arni Kjalar Kristjansson; Laufey Tryggvadottir; Kavita Y. Sarin et al.
Source: check_circle
Crossref

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.

Nature
2020-06-24 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson

Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma.

Nature communications
2020-02-10 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson

Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.

British journal of clinical pharmacology
2020-01-07 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson
grade
Preferred source (of 2)‎

Effective treatment with balneophototherapy and narrowband UVB monotherapy reduces skin homing Th17/Tc17 and Th22/Tc22 effector cells in peripheral blood in patients with psoriasis.

Journal of dermatological science
2019-10-15 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson

A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?

Journal of the European Academy of Dermatology and Venereology
2019-02 | Journal article
Contributors: D.M.L. Saunte; B.M. Piraccini; A.Y. Sergeev; A. Prohić; B. Sigurgeirsson; C. Rodríguez‐Cerdeira; J.C. Szepietowski; J. Faergemann; M. Arabatzis; M. Pereiro et al.
Source: check_circle
Crossref

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.

Journal of the National Cancer Institute
2018-09-01 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson

A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.

The British journal of dermatology
2017-10 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.

Mycoses
2017-09 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.

The British journal of dermatology
2017-09 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations.

NPJ genomic medicine
2017-08-08 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson

Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated with Tonsillectomy: A Randomized Controlled Trial.

Acta dermato-venereologica
2017-03 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.

Journal of the American Academy of Dermatology
2016-11 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Throat Infections are Associated with Exacerbation in a Substantial Proportion of Patients with Chronic Plaque Psoriasis.

Acta dermato-venereologica
2016-08 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.

Mycoses
2016-05 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.

International journal of dermatology
2016-04 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Authors' Response.

Pediatrics
2015-11 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials.

Journal of drugs in dermatology : JDD
2015-08 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

New basal cell carcinoma susceptibility loci.

Nature communications
2015-04 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.

Pediatrics
2015-04 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Cutaneous melanoma in Iceland: changing Breslow's tumour thickness.

Journal of the European Academy of Dermatology and Venereology : JEADV
2015-02 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Analysis of stranded information using an automated procedure for strand specific RNA sequencing.

BMC genomics
2014 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Sequencing degraded RNA addressed by 3' tag counting.

PloS one
2014 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Psoriatic nail disease, a predictor of psoriatic arthritis.

The British journal of dermatology
2014-11 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

The prevalence of onychomycosis in the global population: a literature study.

Journal of the European Academy of Dermatology and Venereology : JEADV
2014-11 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study.

Journal of the European Academy of Dermatology and Venereology : JEADV
2014-08 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab in plaque psoriasis--results of two phase 3 trials.

The New England journal of medicine
2014-07 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.

Human molecular genetics
2014-06 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

The age and genomic integrity of neurons after cortical stroke in humans.

Nature neuroscience
2014-06 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Psoriasis treatment: faster and long-standing results after bathing in geothermal seawater. A randomized trial of three UVB phototherapy regimens.

Photodermatology, photoimmunology & photomedicine
2014-02 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.

Scandinavian journal of immunology
2013-12 | Journal article
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.

2013-05 | Journal article
DOI:

10.1016/j.jaad.2013.03.021

PMID:

23706639

Contributors: Malahias S; Raterink K; Sigurgeirsson B; van Rossem K
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

A variant in FTO shows association with melanoma risk not due to BMI.

2013-04 | Journal article
DOI:

10.1038/ng.2571

PMID:

23455637

Contributors: Aben KK; Akslen LA; Amos CI; Avril MF; Azizi E; Bakker B; Barrett JH; Benediktsdottir KR; Bergman W; Bishop DT et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.

2013-02 | Journal article
DOI:

10.1111/bjd.12110

PMID:

23106107

Contributors: Abe M; Baker DR; Haemmerle S; Konno P; Langley RG; Papavassilis C; Papp KA; Richards HB; Sigurgeirsson B; Thurston HJ
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.

2013-02 | Journal article
DOI:

10.1111/bjd.12112

PMID:

23362969

Contributors: Guettner A; Harfst E; Machacek M; Morita A; Ortonne JP; Papavassilis C; Paul C; Rich P; Roseau K; Schopf RE et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.

2012-10 | Journal article
DOI:

10.1517/13543784.2012.711315

PMID:

22876754

Contributors: Ghannoum M; Sigurgeirsson B
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study.

2012-09 | Journal article
DOI:

10.1111/bjd.12070

PMID:

23020120

Contributors: Guettner A; Harfst E; Machacek M; Morita A; Ortonne JP; Papavassilis C; Paul C; Rich P; Roseau K; Schopf RE et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants.

2012-05 | Journal article
DOI:

10.4049/jimmunol.1102834

PMID:

22491250

Contributors: Arnadottir S; Gudjonsson JE; Johnston A; Olafsson JH; Petersen H; Sigurdardottir SL; Sigurdsson MI; Sigurgeirsson B; Thorleifsdottir RH; Valdimarsson H
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.

2011-12 | Journal article
DOI:

10.1111/j.1468-3083.2011.04373.x

PMID:

22181693

Contributors: Baker DR; Damaj B; Elewski BE; Ghannoum MA; Gupta AK; Hugot S; Korting HC; Ling M; Mayser P; Notter M et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.

2011-11 | Journal article
DOI:

10.1038/ng.926

PMID:

21946351

PMC:

PMC3263694

Contributors: Aben KK; Agnarsson BA; Badea P; Badescu D; Banasik K; Barkardottir RB; Benediktsdottir KR; Catalona WJ; Codreanu O; Constantin A et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

[Erythemogenic UV rays].

2011-07 | Journal article
PMID:

21849709

Contributors: Sigurgeirsson B; Wulf HC
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

[UV-index in Iceland during the summer of 2010].

2011-07 | Journal article
PMID:

21849713

Contributors: Sigurgeirsson B; Wulf HC
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

A melanoma epidemic in Iceland: possible influence of sunbed use.

2010-10 | Journal article
DOI:

10.1093/aje/kwq238

PMID:

20813801

Contributors: Autier P; Boniol M; Byrnes GB; Doré JF; Héry C; Jonasson JG; Olafsdóttir E; Olafsson JH; Sigurdsson T; Sigurgeirsson B et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central

Autier et al. Respond to "A Sunbed Epidemic?"

2010-09 | Journal article
DOI:

10.1093/aje/kwq236

PMID:

20813802

Contributors: Autier P; Boniol M; Byrnes GB; Doré JF; Héry C; Jonasson JG; Olafsdóttir E; Olafsson JH; Sigurdsson T; Sigurgeirsson B et al.
Source: Self-asserted source
Bárður Sigurgeirsson via Europe PubMed Central
Items per page:
Page 1 of 3